98%
921
2 minutes
20
To ascertain the effects of environmental temperature on blood rheology, ten subjects performed two exercise trials, in random order, at approximately 60% VO(2) max for 45-min. One trial was conducted in thermoneutral environment (20 ± 1°C), while the other was performed in hot dry condition (36 ± 1°C). Venous blood was removed at rest; following exercise and recovery. Blood was measured for lactate, haematocrit, and hemoglobin, while plasma was measured for viscosity, and fibrinogen. Plasma volume changes were estimated from Hct and Hb readings. Exercise was followed by a significant (P < 0.05) reduction in plasma volume in both test trials. Lactate increased significantly (P < 0.05) following exercise with no difference being observed between trials. When post exercise raw data were not adjusted for plasma volume changes, a significant increase (P < 0.05) in plasma viscosity (PV) and plasma fibrinogen (Fb) was found with no difference between thermoneutral and hot trials. When the raw data post exercise for PV and Fb were adjusted for plasma volume changes, no significant difference between rest and post exercise was demonstrated. Rheological variables returned to the pre-exercise level at the end of recovery. In conclusion, vigorous exercise transiently increased PV and Fb, and the added heat stress did not affect these responses more than exercise alone. The mechanism responsible for the increase in PV and Fb in response to vigorous exercise appears to be related to plasma shifts from intravascular to the extravascular spaces rather than plasma volume loss.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3233/CH-2010-1329 | DOI Listing |
Psychol Med
September 2025
Department of Psychiatry, https://ror.org/04wjghj95The First Hospital of China Medical University, Shenyang, China.
Background: This study investigates structural abnormalities in hippocampal subfield volumes and shapes, and their association with plasma CC chemokines in individuals with major depressive disorder (MDD).
Methods: A total of 61 patients with MDD and 65 healthy controls (HC) were recruited. All participants underwent high-resolution T1-weighted imaging and provided blood samples for the detection of CC chemokines (CCL2, CCL7, and CCL11).
BMJ
September 2025
Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.
Objective: To determine the effect of a prepregnancy lifestyle intervention on glucose tolerance in people at higher risk of gestational diabetes mellitus.
Design: Single centre randomised controlled trial (BEFORE THE BEGINNING).
Setting: University hospital in Trondheim, Norway.
J Thromb Thrombolysis
September 2025
Central Laboratory of Yongchuan Hospital, Chongqing Medical University, No. 439, Xuanhua Road, Yongchuan District, Chongqing, 402160, China.
In vitro assessment of the inhibitory effect of antiplatelet drugs on platelet aggregation is frequently employed to guide personalized antiplatelet therapy in clinical practice. However, existing methods for detecting platelet aggregation rely heavily on high concentrations of exogenous agonists, which may obscure part of the inhibitory effect of antiplatelet drugs and lead to an underestimation of their effects. This study validates a novel analytical strategy for evaluating the effects of antiplatelet drugs by quantifying the microscopic three-dimensional morphological parameters of platelet aggregates formed through spontaneous aggregation on a glass surface.
View Article and Find Full Text PDFInt J Pharm
September 2025
Department of Pharmaceutics, VCU School of Pharmacy, Richmond, VA 23298, USA. Electronic address:
Multiple exogenous supplements to achieve ketosis using the oral route have been developed to elevate blood BHB levels on demand and in a controllable fashion. The focus is now shifting to evaluating these supplements as potential therapeutic agents and developing strategies to not only achieve ketosis but also maintain it. One such strategy is to administer these as a continuous IV infusion.
View Article and Find Full Text PDFJ Vet Pharmacol Ther
September 2025
Elanco Animal Health, Sèvres, France.
Ilunocitinib, a novel Janus kinase inhibitor, is indicated for managing pruritus and skin lesions associated with canine allergic and atopic dermatitis. Pharmacokinetics of ilunocitinib were investigated following single intravenous and oral administrations, both in fed and fasted states. Dose proportionality was assessed using oral doses ranging from 0.
View Article and Find Full Text PDF